FDA 483 - Cal-Maine Foods, Inc. - June 02, 2011

This FDA Form 483 document outlines an observation made during an inspection of a facility involved in egg production. The primary finding relates to the firm's Salmonella Enteritidis (SE) prevention plan.

The document states that the written SE prevention plan is deficient, specifically lacking appropriate SE prevention measures. The core issue identified is the firm's failure to establish written procedures for egg testing for Salmonella Enteritidis. This deficiency is noted to occur specifically "following a positive environmental test of the pullet environment."

The observation indicates a gap in the firm's quality system and manufacturing controls concerning food safety, particularly in response to a known risk factor (positive environmental test). The implication is that without such procedures, the firm may not be adequately preventing SE contamination in eggs, especially after an environmental detection of the pathogen in the pullet housing. This could lead to potential public health risks and regulatory non-compliance.